| SKINDEX-29 SCALES | ||
---|---|---|---|
 | Symptoms Mean SD (min-max) | Emotional Mean SD (min-max) | Functioning Mean SD (min-max) |
Total sample (n° = 45) | 43.33 ± 20.22 (07-96) | 30.33 ± 14.16 (05-67) | 26.85 ± 17.57 (0-62) |
Sex | Â | Â | Â |
Male (n° = 29) | 41.87 ± 18.55 (07-82) | 29.31 ± 12.98 (05-57) | 24.71 ± 16.74 (00-56) |
Female (n° = 16) | 45.98 ± 23.26 (07-96) | 32.18 ± 16.35 (05-67) | 30.73 ± 18.93 (00-62) |
Age - 3 levels | Â | Â | Â |
34-54 years (n° = 13) | 42.58 ± 20.64 (07-71) | 29.80 ± 14.45 (05-50) | 24.67 ± 21.97 (00-60) |
55-65 years (n° = 19) | 46.05 ± 23.20 (07-96) | 32.23 ± 16.24 (05-67) | 29.49 ± 15.82 (04-62) |
> 65 years (n° = 13) | 40.10 ± 15.57 (07-71) | 28.07 ± 10.90 (05-50) | 25.16 ± 15.96 (00-52) |
Age 3 and Male | Â | Â | Â |
34-54 years (n° = 6) | 48.80 ± 13.67 (25-64) | 34.16 ± 09.57 (17-45) | 19.79 ± 18.71 (04-54) |
55-65 years (n° = 13) | 42.30 ± 23.04 (07-82) | 29.61 ± 16.13 (05-57) | 26.92 ± 16.12 (04-56) |
> 65 years (n° = 10) | 37.14 ± 14.20 (07-53) | 26.00 ± 09.94 (05-37) | 24.79 ± 17.52 (00-52) |
Age 3 and Female | Â | Â | Â |
34-54 years (n° = 7) | 37.24 ± 24.98 (07-71) | 26.07 ± 17.49 (05-50) | 28.86 ± 25.09 (00-60) |
55-65 years (n° = 6) | 54.16 ± 23.41 (28-96) | 37.91 ± 16.38 (20-67) | 35.06 ± 14.93 (20-62) |
> 65 years (n° = 3) | 50.00 ± 18.89 (35-71) | 35.00 ± 13.22 (25-50) | 26.38 ± 12.02 (12-33) |
Clinical outcome | Â | Â | Â |
Partial remission (n° = 16) | 45.98 ± 18.98 (07-71) | 32.18 ± 13.28 (05-50) | 28.51 ± 19.55 (00-56) |
No remission (n° = 29) | 41.87 ± 21.06 (07-96) | 29.31 ± 14.74 (05-67) | 25.93 ± 16.68 (00-62) |
Grade skin toxicity | Â | Â | Â |
2 (n° = 31) | 39.28 ± 19.64 (07-82) | 27.50 ± 13.75 (05-57) | 23.11 ± 16.28 (00-60) |
3 (n° = 14) | 52.29 ± 19.18 (18-96) | 36.60 ± 13.43 (12-67) | 35.12 ± 18.08 (06-62) |